HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease.

Abstract
Subthalamic nucleus deep brain stimulation improves motor symptoms and quality of life in advanced Parkinson's disease. As after other life-altering surgeries, suicides have been reported following deep brain stimulation for movement disorders. We sought to determine the suicide rate following subthalamic nucleus deep brain stimulation for Parkinson's disease by conducting an international multicentre retrospective survey of movement disorder and surgical centres. We further sought to determine factors associated with suicide attempts through a nested case-control study. In the survey of suicide rate, 55/75 centres participated. The completed suicide percentage was 0.45% (24/5311) and attempted suicide percentage was 0.90% (48/5311). Observed suicide rates in the first postoperative year (263/100,000/year) (0.26%) were higher than the lowest and the highest expected age-, gender- and country-adjusted World Health Organization suicide rates (Standardized Mortality Ratio for suicide: SMR 12.63-15.64; P < 0.001) and remained elevated at the fourth postoperative year (38/100,000/year) (0.04%) (SMR 1.81-2.31; P < 0.05). The excess number of deaths was 13 for the first postoperative year and one for the fourth postoperative year. In the case-control study of associated factors, 10 centres participated. Twenty-seven attempted suicides and nine completed suicides were compared with 70 controls. Postoperative depression (P < 0.001), being single (P = 0.007) and a previous history of impulse control disorders or compulsive medication use (P = 0.005) were independent associated factors accounting for 51% of the variance for attempted suicide risk. Attempted suicides were also associated (P < 0.05) with being younger, younger Parkinson's disease onset and a previous suicide attempt. Completed suicides were associated with postoperative depression (P < 0.001). Postoperative depression remained a significant factor associated with attempted and completed suicides after correction for multiple comparisons using the stringent Bonferroni correction. Mortality in the first year following subthalamic nucleus deep brain stimulation has been reported at 0.4%. Suicide is thus one of the most important potentially preventable risks for mortality following subthalamic nucleus deep brain stimulation for Parkinson's disease. Postoperative depression should be carefully assessed and treated. A multidisciplinary assessment and follow-up is recommended.
AuthorsValerie Voon, Paul Krack, Anthony E Lang, Andres M Lozano, Kathy Dujardin, Michael Schüpbach, James D'Ambrosia, Stephane Thobois, Filippo Tamma, Jan Herzog, Johannes D Speelman, Johan Samanta, Cynthia Kubu, Helene Rossignol, Yu-Yan Poon, Jean A Saint-Cyr, Claire Ardouin, Elena Moro
JournalBrain : a journal of neurology (Brain) Vol. 131 Issue Pt 10 Pg. 2720-8 (Oct 2008) ISSN: 1460-2156 [Electronic] England
PMID18941146 (Publication Type: Journal Article, Multicenter Study)
Topics
  • Deep Brain Stimulation (adverse effects)
  • Depression (psychology)
  • Epidemiologic Methods
  • Female
  • Humans
  • Male
  • Middle Aged
  • Movement Disorders (surgery)
  • Neuropsychological Tests
  • Parkinson Disease (physiopathology, psychology, therapy)
  • Postoperative Period
  • Psychiatric Status Rating Scales
  • Subthalamic Nucleus (physiopathology)
  • Suicide
  • Suicide, Attempted

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: